Congratulations, you’re now registered! Let us know what news and updates you want to hear about and we’ll send them straight to your inbox. Waitrose Community Matters Champion Julie Atkinson was delighted to award Sarah Walters of the Derbyshire Asbes…
Metronomic oral vinorelbine is effective in metastatic NSCLC and malignant pleural mesothelioma, but all the studies published thus far were based upon a variety of empirical and possibly suboptimal schedules, with inconsistent results. Mathematical mo…
The U.S. Department of Defense (DOD) awarded three grants totaling more than $3 million to researchers at the University of Hawaii Cancer Center last month to advance their studies of mesothelioma. The awards were part of the Peer Reviewed Cancer Research Program funded by the DOD. The University of Hawaii has been a national leader…
The post Univ. of Hawaii Awarded $3M Mesothelioma Research Grants appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
The U.S. Department of Defense (DOD) awarded three grants totaling more than $3 million to researchers at the University of Hawaii Cancer Center last month to advance their studies of mesothelioma. The awards were part of the Peer Reviewed Cancer Research Program funded by the DOD. The University of Hawaii has been a national leader…
The post Univ. of Hawaii Awarded $3M Mesothelioma Research Grants appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
The U.S. Department of Defense multiyear grants will advance mesothelioma research at the University of Hawaii Cancer Center.
Mesothelioma, a cancer caused by asbestos exposure, is rare, aggressive and fatal. Researches are discovering more and more about this disease daily, and with that, they are one step closer to finding more effective treatments. In a most recent study, scientists looked into why, after initial treatments, the cancer cells become immune to the chemotherapy,
People searching for early-detection cancer tests may now find the answers they’re looking for through a simple blood test. According to Dr. Akbar Khan at the Medicor Cancer Centres in Toronto, it’s a test that costs up to $1,700, but it could save you…
Promising results from another phase of a clinical trial for an immunotherapy drug for mesothelioma, CRS-207, have been released.
It’s in Des Sayegh’s nature to help others, but his work rebuilding cyclone-ravaged Western Australia nearly 40 years ago is helping to kill him. The 81-year-old Aucklander has just won a confidential payout from Australia for asbestos exposure while w…
Standup comedian Quincy Jones lived his dream last week in Los Angeles. Jones, 31, taped an hour-long standup comedy special that will air June 2 at 10 p.m. on HBO. He is living the wish he made after his 2015 peritoneal mesothelioma diagnosis. It was the legacy he wanted to leave when he is gone…
The post Exclusive: Quincy Jones Talks Mesothelioma & Comedy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
Standup comedian Quincy Jones lived his dream last week in Los Angeles. Jones, 31, taped an hour-long standup comedy special that will air June 2 at 10 p.m. on HBO. He is living the wish he made after his 2015 peritoneal mesothelioma diagnosis. It was the legacy he wanted to leave when he is gone…
The post Exclusive: Quincy Jones Talks Mesothelioma & Comedy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.
Comedian Quincy Jones talks to Asbestos.com about how he’s using his upcoming HBO comedy special to raise mesothelioma awareness.
Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and 59% response rate in patients with malignant pleural mesothelioma (MPM), according to the results of a phase Ib trial.
Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and 59% response rate in patients with malignant pleural mesothelioma (MPM), according to…
Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and 59% response rate in patients with malignant pleural mesothelioma (MPM), according to…